| MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib J Bean, C Brennan, JY Shih, G Riely, A Viale, L Wang, D Chitale, N Motoi, ... Proceedings of the National Academy of Sciences 104 (52), 20932-20937, 2007 | 1950 | 2007 |
| Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists … NI Lindeman, PT Cagle, MB Beasley, DA Chitale, S Dacic, G Giaccone, ... Journal of Thoracic Oncology 8 (7), 823-859, 2013 | 1928 | 2013 |
| Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma GJ Riely, MG Kris, D Rosenbaum, J Marks, A Li, DA Chitale, K Nafa, ... Clinical cancer research 14 (18), 5731-5734, 2008 | 717 | 2008 |
| Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1 JC Ricarte-Filho, M Ryder, DA Chitale, M Rivera, A Heguy, M Ladanyi, ... Cancer research 69 (11), 4885-4893, 2009 | 641 | 2009 |
| Genomic and biological characterization of exon 4 KRAS mutations in human cancer M Janakiraman, E Vakiani, Z Zeng, CA Pratilas, BS Taylor, D Chitale, ... Cancer research 70 (14), 5901-5911, 2010 | 307 | 2010 |
| Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma JL Marks, S Broderick, Q Zhou, D Chitale, AR Li, MF Zakowski, MG Kris, ... Journal of thoracic oncology 3 (2), 111-116, 2008 | 288 | 2008 |
| Genetic predictors of MEK dependence in non–small cell lung cancer CA Pratilas, AJ Hanrahan, E Halilovic, Y Persaud, J Soh, D Chitale, ... Cancer research 68 (22), 9375-9383, 2008 | 275 | 2008 |
| Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma JL Marks, Y Gong, D Chitale, B Golas, MD McLellan, Y Kasai, L Ding, ... Cancer research 68 (14), 5524-5528, 2008 | 271 | 2008 |
| An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors D Chitale, Y Gong, BS Taylor, S Broderick, C Brennan, R Somwar, ... Oncogene 28 (31), 2773-2783, 2009 | 253 | 2009 |
| EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression AR Li, D Chitale, GJ Riely, W Pao, VA Miller, MF Zakowski, V Rusch, ... The Journal of Molecular Diagnostics 10 (3), 242-248, 2008 | 252 | 2008 |
| Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM D Kong, E Heath, W Chen, ML Cher, I Powell, L Heilbrun, Y Li, S Ali, ... PloS one 7 (3), e33729, 2012 | 241 | 2012 |
| Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases JM Wu, MJ Fackler, MK Halushka, DW Molavi, ME Taylor, WW Teo, ... Clinical cancer research 14 (7), 1938-1946, 2008 | 238 | 2008 |
| False‐negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 consecutive cases of missed breast cancer VI Shah, U Raju, D Chitale, V Deshpande, N Gregory, V Strand Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 169 | 2003 |
| Significance of p16 in site-specific HPV positive and HPV negative head and neck squamous cell carcinoma JK Stephen, G Divine, KM Chen, D Chitale, S Havard, MJ Worsham Cancer and clinical oncology 2 (1), 51, 2013 | 159 | 2013 |
| Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans JM Reinersman, ML Johnson, GJ Riely, DA Chitale, AD Nicastri, GA Soff, ... Journal of Thoracic Oncology 6 (1), 28-31, 2011 | 140 | 2011 |
| Bioenergetic adaptations in chemoresistant ovarian cancer cells S Dar, J Chhina, I Mert, D Chitale, T Buekers, H Kaur, S Giri, A Munkarah, ... Scientific reports 7 (1), 8760, 2017 | 135 | 2017 |
| Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment D Kong, E Heath, W Chen, M Cher, I Powell, L Heilbrun, Y Li, S Ali, ... American journal of translational research 4 (1), 14, 2012 | 97 | 2012 |
| Comparative analysis of breast cancer phenotypes in African American, white American, and west versus east African patients: correlation between African ancestry and triple … E Jiagge, AS Jibril, D Chitale, JM Bensenhaver, B Awuah, M Hoenerhoff, ... Annals of surgical oncology 23, 3843-3849, 2016 | 85 | 2016 |
| College of American Pathologists International Association for the Study of Lung Cancer and Association for Molecular Pathology Molecular testing guideline for selection of … NI Lindeman, PT Cagle, MB Beasley, DA Chitale, S Dacic, G Giaccone, ... J Mol Diagn 15 (4), 415-53, 2013 | 84 | 2013 |
| Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer ON Kryvenko, M Jankowski, DA Chitale, D Tang, A Rundle, S Trudeau, ... Modern Pathology 25 (7), 1023-1032, 2012 | 82 | 2012 |
